Literature DB >> 2802849

Effect of crossover on the statistical power of randomized studies.

G S Weinstein1, B Levin.   

Abstract

Randomized studies involving long-term follow-up are vulnerable to the effects of unplanned crossover. In surgical studies, such crossover usually occurs when control patients become more symptomatic and undergo operation. In several large studies of coronary bypass grafting, crossover ranged from 25% to 38%. The most common way of dealing with this problem is to apply the "intention-to-treat" principle, which analyzes such crossovers with their originally assigned groups. Besides the logical problem of counting a control patient who actually undergoes operation as "nonsurgical," a more subtle problem arises in terms of statistical power. When statistical power is low, a truly effective treatment may be mistakenly labeled as no better than control, causing a potentially valuable form of therapy to be ignored or discarded. This analysis demonstrates that crossover may have a profound effect on the statistical power of randomized studies and presents a method for predicting the effect of such crossover on statistical power.

Entities:  

Mesh:

Year:  1989        PMID: 2802849     DOI: 10.1016/s0003-4975(10)66846-4

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  9 in total

1.  Clinical and prophylactic trials with assured new treatment for those at greater risk: I. A design proposal.

Authors:  M O Finkelstein; B Levin; H Robbins
Journal:  Am J Public Health       Date:  1996-05       Impact factor: 9.308

2.  Limitations in Clinical Trials Leading to Anticancer Drug Approvals by the US Food and Drug Administration.

Authors:  Talal Hilal; Miguel Gonzalez-Velez; Vinay Prasad
Journal:  JAMA Intern Med       Date:  2020-08-01       Impact factor: 21.873

3.  Subscapularis-sparing approaches in shoulder arthroplasty: A systematic review.

Authors:  Sandra Lee; Huda Sardar; Nolan S Horner; Latifah Al Mana; Bruce S Miller; Moin Khan; Bashar Alolabi
Journal:  J Orthop       Date:  2021-02-26

Review 4.  Randomized controlled trials in neurosurgery.

Authors:  Radwan Takroni; Sunjay Sharma; Kesava Reddy; Nirmeen Zagzoog; Majid Aljoghaiman; Mazen Alotaibi; Forough Farrokhyar
Journal:  Surg Neurol Int       Date:  2022-08-26

Review 5.  Induced Bias Due to Crossover Within Randomized Controlled Trials in Surgical Oncology: A Meta-regression Analysis of Minimally Invasive versus Open Surgery for the Treatment of Gastrointestinal Cancer.

Authors:  George Garas; Sheraz R Markar; George Malietzis; Hutan Ashrafian; George B Hanna; Emmanouil Zacharakis; Long R Jiao; Athanassios Argiris; Ara Darzi; Thanos Athanasiou
Journal:  Ann Surg Oncol       Date:  2017-11-06       Impact factor: 5.344

6.  Prevalence and Impact of Treatment Crossover in Cardiac Surgery Randomized Trials: A Meta-Epidemiologic Study.

Authors:  Mario Gaudino; Stephen E Fremes; Marc Ruel; Antonino Di Franco; Michele Di Mauro; Joanna Chikwe; Giacomo Frati; Leonard N Girardi; David P Taggart; Giuseppe Biondi-Zoccai
Journal:  J Am Heart Assoc       Date:  2019-10-30       Impact factor: 5.501

7.  Two-Year Outcomes for the Double-Blind, Randomized, Sham-Controlled Study of Targeted Lung Denervation in Patients with Moderate to Severe COPD: AIRFLOW-2.

Authors:  Arschang Valipour; Pallav L Shah; Felix J Herth; Christophe Pison; Christian Schumann; Ralf-Harto Hübner; Peter I Bonta; Romain Kessler; Wolfgang Gesierich; Kaid Darwiche; Bernd Lamprecht; Thierry Perez; Dirk Skowasch; Gaetan Deslee; Armelle Marceau; Frank C Sciurba; Reinoud Gosens; Jorine E Hartman; Francesca Conway; Marina Duller; Martin Mayse; Holly S Norman; Dirk-Jan Slebos
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-11-05

Review 8.  Machine Learning Methods to Predict Acute Respiratory Failure and Acute Respiratory Distress Syndrome.

Authors:  An-Kwok Ian Wong; Patricia C Cheung; Rishikesan Kamaleswaran; Greg S Martin; Andre L Holder
Journal:  Front Big Data       Date:  2020-11-23

9.  Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis.

Authors:  Eliano P Navarese; Alexandra J Lansky; Dean J Kereiakes; Jacek Kubica; Paul A Gurbel; Diana A Gorog; Marco Valgimigli; Nick Curzen; David E Kandzari; Marc P Bonaca; Marc Brouwer; Julia Umińska; Milosz J Jaguszewski; Paolo Raggi; Ron Waksman; Martin B Leon; William Wijns; Felicita Andreotti
Journal:  Eur Heart J       Date:  2021-12-01       Impact factor: 29.983

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.